GDC-0077
Maka nyocha sayensị naanị, ọ bụghị maka ndị ọrịa.
Nkọwa ngwaahịa
Mkpado ngwaahịa
| Nha ngwugwu | Nnweta | Ọnụ ego (USD) |
Aha kemịkalụ:
(S) -2- ((2-- (S) -4- (difluoromethyl) -2-oxooxazolidin-3-yl) -5,6-dihydrobenzo [f] imidazo [1,2-d] [1,4] ]oxazepin-9-yl) amino) propanamide
Koodu Ọchịchọ:
C[C@@H](C(N)=O)NC1=CC=C(C2=NC(N3[C@H](C(F)F)COC3=O)=CN2CCO4)C4=C1
Koodu InChi:
InChi=1S/C18H19F2N5O4/c1-9(16(21)26)22-10-2-3-11-13(6-10)28-5-4-24-7-14(23-17(11) 24)25-12 (15(19)20)8-29-18(25)27/h2-3,6-7,9,12,15,22H,4-5,8H2,1H3,(H2,21 ,26)/t9-,12-/m0/s1
Igodo InChi:
SGEUNORSOZVTOL-CABZTGNLSA-N
Okwu:
GDC-0077; GDC 0077; GDC0077
Solubility:DMSO
Nchekwa:
Nkọwa:
GDC-0077 bụ ihe mgbochi PI3K dị n'ọnụ nwere ọrụ antineoplastic nwere ike. A na-ewepụta GDC-0077 site na patent WO 2017001645 A1, usoro I.
Ebumnuche: PI3K
